Potential Novel Schizophrenia Treatments

A comprehensive discussion on new treatment options for patients with schizophrenia, highlighting the potential for earlier intervention to optimize treatment outcomes.

EP: 1.Burden, Stigma, and Prevalence of Schizophrenia

EP: 2.Exploration into the Management of the Three Symptom Domains of Schizophrenia

EP: 3.Insights on the Pathophysiology of Schizophrenia

EP: 4.Physician Awareness of Cognitive Dysfunction in Schizophrenia

Now Viewing

EP: 5.Potential Novel Schizophrenia Treatments

EP: 6.Future Perspectives on Schizophrenia Care

Related Videos

Related Content

Advertisement

January 21st 2025

Rural Realities: Resilience and Revelations From a Year in Psychiatry

Grace Lehnerdt, MD

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

January 18th 2025

Schizophrenia in 2025: The Dawn of a New Era?

Michael Asbach, DMSc, PA-C, Psych-CAQ

May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD

January 16th 2025

Disappointing Data From Phase III CONNEX for Iclepertin in Addressing Cognition Impairment in Schizophrenia

Heidi Anne Duerr, MPH

January 14th 2025

Discontinuing Antipsychotics

Joshua Feder, MD, DFAPA Charmi Patel Rao, MD, DFAACAP

Related Content

Advertisement

January 21st 2025

Rural Realities: Resilience and Revelations From a Year in Psychiatry

Grace Lehnerdt, MD

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

January 18th 2025

Schizophrenia in 2025: The Dawn of a New Era?

Michael Asbach, DMSc, PA-C, Psych-CAQ

May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD

January 16th 2025

Disappointing Data From Phase III CONNEX for Iclepertin in Addressing Cognition Impairment in Schizophrenia

Heidi Anne Duerr, MPH

January 14th 2025

Discontinuing Antipsychotics

Joshua Feder, MD, DFAPA Charmi Patel Rao, MD, DFAACAP